Category Archives: Agency Specific

National Institute of Justice Graduate Research Fellowship, Fiscal Year 2020

Posted on by

The U.S. Department of Justice (DOJ), Office of Justice Programs (OJP), National Institute of Justice (NIJ) is seeking applications for funding innovative doctoral dissertation research that is relevant to preventing and controlling crime, and ensuring the fair and impartial administration of criminal justice in the United States. This program furthers the Department’s mission by increasing the pool of researchers who are engaged in providing science-based solutions to problems relevant to criminal and juvenile justice policy and practice in the United States. This integrates into a single solicitation for two previously separate fellowship solicitations in Science, Technology, Engineering, and Mathematics (STEM) and Social and Behavior Sciences (SBS).

Proposal Deadline: April 15, 2020.

The Graduate Research Fellowship (GRF) program provides grants to accredited academic institutions to support outstanding doctoral students whose dissertation research is relevant to criminal justice. Applicant academic institutions are eligible to apply only if:

  • The student is currently enrolled in a Ph.D. program in the sciences or engineering; and
  • The student’s proposed dissertation research has demonstrable relevance to preventing and controlling crime, and/or ensuring the fair and impartial administration of criminal justice, in the United States.

To learn more about the program, including answers to Frequently Asked Questions, go to https://www.nij.ojp.gov/GRF. Look for information on a webinar scheduled for 1:00 p.m. (eastern time) on February 4, 2020. Webinar slides and a transcript will be posted after the event.

Proposals addressing one or more of the following areas are particularly encouraged:

  • Reducing and preventing violent crime;
  • Addressing drug trafficking, drug markets, and drug-related violence;
  • Promoting law enforcement officer safety, health, and wellness;
  • Rescuing and restoring crime victims;
  • Securing our nation’s borders;
  • Enhancing law enforcement investigations and prosecutions, and
  • Investigating psychopathological, physiological, or biological correlates to offending behaviors and/or victimization.

Additional information can be found on grants.gov and in the program announcement.

Measurement Science and Engineering (MSE) Research Grant Programs

Posted on by

The Department of Commerce’s National Institute of Standards and Technology (NIST) is soliciting applications for financial assistance for Fiscal Year 2020 (FY20) within the Office of the Associate Director for Innovation and Industry Services (ADIIS).

Program Description: The ADIIS Grant Program supports activities that develop, expand, strengthen, or sustain NIST partnership programs within the ADIIS Directorate through measurements, standards, data, industry and technology studies, and technology research and development (R&D). Specifically, the ADIIS Grant Program seeks to support technology innovation and service to American industry in the following fields: bioscience, chemistry, dimensional metrology, electronics, engineering, infrastructure, information technology, manufacturing, manufacturing metrology, materials science and engineering, nanotechnology, neutron research, optics, and physics.

The ADIIS Directorate’s current partnership programs include the Baldrige Performance Excellence Program, the Hollings Manufacturing Extension Partnership (MEP), programs within the NIST Office of Advanced Manufacturing, and programs within the NIST Technology Partnerships Office. Financial assistance may be provided to bolster measurements, standards, data and technology R&D within these partnership programs, or through new partnerships, to:

  • Advance early-stage research and development for industry
  • Enhance opportunities in manufacturing through innovation
  • Strengthen supplier programs for small and medium manufacturers
  • Encourage the transfer and commercialization of research and technology from institutions of higher education, federal laboratories, other federally funded research programs, and nonprofit research institutes
  • Create jobs or promote workforce development
  • Realize or sustain metrology needs in American industry, including through technical metrology training programs for manufacturers

Eligibility for all programs listed in this Notice of Funding Opportunity (NOFO) includes all non-Federal entities, including institutions of higher education, non-profit organizations, for-profit organizations, state and local governments, Indian tribes, hospitals, foreign public entities, and foreign governments. Please note that individuals and unincorporated sole proprietors are not considered “non-Federal entities” and are not eligible to apply under this NOFO. The NOFO’s full text can be found here and downloaded as a PDF or a zip file.

Department of Defense Fiscal Year 2020 (FY20) Peer Reviewed Cancer Research Program and Peer Reviewed Orthopaedic Research Program Pre-Announcements

Posted on by

The Department of Defense (DoD) recently released pre-announcements for the Fiscal Year 2020 (FY20) Department of Defense (DoD) Peer Reviewed Cancer Research Program and Peer Reviewed Orthopaedic Research Program managed by the office of Congressionally Directed Medical Research Programs (CDMRP) https://cdmrp.army.mil/pubs/press/cdmrp_presses.

Peer Reviewed Cancer Research Program:

  • Virtual Cancer Center – Director Award
  • Career Development Award – Fellow Option
  • Career Development Award – Scholar Option
  • Idea Award
  • Impact Award
  • Behavioral Health Science Award
  • Translational Team Science Award

Peer Reviewed Orthopaedic Research Program:

  • Applied Research Award
  • Clinical Trial Award
  • Clinical Translational Research Award

Descriptions of each of the anticipated funding opportunities, eligibility, key mechanism elements, and funding can be found in the Program pre-announcements.  FY20 pre-announcements can be found in the CDMRP home page features at https://cdmrp.army.mil. Subsequent notifications will be sent when the program announcements/funding opportunities are released.

Defense Health Program Department of Defense Peer Reviewed Cancer Research Program Anticipated Funding Opportunities for Fiscal Year 2020 (FY20)

Posted on by

The FY20 Defense Appropriations Act provides funding to the Department of Defense Peer Reviewed Cancer Research Program (PRCRP) to support innovative, high-impact cancer research.  As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency J9, Research and Development Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation.  The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Development Command (USAMRDC).

The PRCRP is providing the information in this pre-announcement to allow investigators time to plan and develop ideas for submission to the anticipated FY20 funding opportunity.  This pre-announcement should not be construed as an obligation by the Government.  The FY20 PRCRP Program Announcements and General Application Instructions for the following award mechanisms will be posted on the Grants.gov website.  Pre-application and application deadlines will be available when the Program Announcements are released. 

Congressionally Directed Topic Areas:  The PRCRP appropriation of $110,000,000 will provide funds for research into cancers not addressed in the breast, pancreatic, prostate, ovarian, kidney, lung, melanoma, and rare cancer research programs.  To be considered for funding, applications for the FY20 PRCRP must address at least one of the FY20 PRCRP Topic Areas as directed by Congress.  Research applications in the areas of breast, prostate, lung (excluding mesothelioma), kidney, melanoma, pancreatic, rare cancer, or ovarian cancer will not be accepted. The inclusion of the individual rare cancer research program shall not prohibit the PRCRP from funding the below mentioned cancers or cancer subtypes that may be rare by definition.

The FY2020 PRCRP Topic Areas are:

  • Bladder cancer
  • Blood cancers
  • Brain cancer
  • Colorectal cancer
  • Esophageal cancer
  • Head and neck cancer
  • Immunotherapy
  • Liver cancer
  • Mesothelioma
  • Metastatic cancer
  • Neuroblastoma
  • Pediatric, adolescent, and young adult cancers (PAYAC)
  • Pediatric brain tumors
  • Stomach cancer

The FY20 PRCRP Military Health Focus Areas are listed below:

It is central to the vision and mission of the PRCRP that applications address how the proposed research is related to military health, mission readiness, and the cancer health needs of both deployed and non-deployed military personnel, their dependents, Veterans, and other military beneficiaries (i.e., family members of retirees).  The FY20 PRCRP requires all applications to answer at least one of the following Military Health Focus Areas:

  • Environmental/exposure risk factors associated with cancer
  • Mission Readiness
    • Gaps in cancer prevention, early detection/diagnosis, prognosis, and/or treatment that may affect the general population but have a particularly profound impact on the health and well-being of military Service members, Veterans, and their beneficiaries
    • Gaps in quality of life and/or survivorship that may affect the general population but have a particularly profound impact on the health and well-being of military Service members, Veterans, and their beneficiaries

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline.  All applications must conform to the final Program Announcements and General Application Instructions that will be available for electronic downloading from the Grants.gov website.  The application package containing the required forms for each award mechanism will also be found on Grants.gov.  A listing of all CDMRP and other USAMRDC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420. 

Submission deadlines are not available until the Program Announcements are released.  For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org.  For more information about the PRCRP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.army.mil).

Additional information, including proposal and award mechanisms, can be found on the CDMRP site.

Defense Health Program Department of Defense Peer Reviewed Orthopaedic Research Program Anticipated Funding Opportunities for Fiscal Year 2020 (FY20)

Posted on by

The FY20 Defense Appropriations Act provides funding to the Department of Defense Peer Reviewed Orthopaedic Research Program (PRORP) to support innovative, high-impact, clinically-relevant research to advance optimal treatment and rehabilitation from musculoskeletal injuries.  As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency J9, Research and Development Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation.  The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Development Command (USAMRDC).

The PRORP is providing the information in this pre-announcement to allow investigators time to plan and develop ideas for submission to the anticipated FY20 funding opportunities.  This pre-announcement should not be construed as an obligation by the Government.  The FY20 PRORP Program Announcements and General Application Instructions for the following award mechanisms will be posted on the Grants.gov website.  Pre-application and application deadlines will be available when the Program Announcements are released. 

Applications submitted to the FY20 PRORP must address one or more of the following FY20 Focus Areas:

  1. Compartment Syndrome: Novel treatment strategies to improve current diagnoses for compartment syndrome. Alternatives to intracompartmental pressure measurements are encouraged.
  2. Limb Stabilization and Protection: Development and/or clinical assessment of rapid limb stabilization and novel wound protectants for severely wounded limbs to enable transport at the point of need.
  3. Orthotic Devices: Refinement of high-performance novel orthotic devices designed to enhance whole person performance and decrease pain in patients with limb salvage and impairment.
  4. Osseointegration: Identification of best practices to address infection, rejection, and/or failure of percutaneous osseointegrated prosthetic limbs.
  5. Retention Strategies: Development, optimization, and/or validation of battlefield-feasible diagnostic capabilities, decision support tools, interventions, and/or rehabilitation strategies that can facilitate retention on duty for common combat-related musculoskeletal injuries.  Biomarker studies are excluded.  The current standard of care must be noted.  The rehabilitation strategy and the standard of care must be specified, as applicable.
    1. Point of Injury: Battlefield-feasible strategies that can be utilized at or near the point of injury to allow an injured Service member to remain on duty and stay on mission without the need for immediate evacuation.
    2. Point of Duty: Strategies that can be utilized along the continuum of care to allow an injured Service member to return to duty without separation from Service.
  6. Tissue Regeneration Therapeutics: Development of advanced tissue regeneration therapeutics in nerve, muscle (to include volumetric muscle loss), and/or composite tissue for the restoration of traumatically injured extremities.  Isolated bone or cartilage tissue engineering studies are excluded.
  7. Translation of Early Findings: Translation of early research findings in the orthopaedic surgical care topic areas listed below to move the research toward clinical trials and clinical practice.
    1. Soft Tissue Trauma: Strategies to develop and/or identify musculoskeletal extremity soft tissue trauma treatments for anterior cruciate ligament (ACL) or shoulder instability only, to optimize return to duty, work, or reintegration.
    2. Fracture-Related Infection: Strategies to decrease the burden of fracture-related infections (may include prevention, early detection, or improved eradication).  Alternatives to systemic and/or local antibiotic delivery are encouraged. 

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline.  All applications must conform to the final Program Announcements and General Application Instructions that will be available for electronic downloading from the Grants.gov website.  The application package containing the required forms for each award mechanism will also be found on Grants.gov.  A listing of all CDMRP and other USAMRDC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420. 

Submission deadlines are not available until the Program Announcements are released.  For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org.  For more information about the PRORP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.army.mil).

Additional information, including the award mechanisms, can be found on the CDMRP site.